<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7454523\results\search\disease\results.xml">
  <result pre="Gerges HarbJad[], Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese" exact="American" post="University, P.O. Box 36, ByblosLebanonNoureldineHussein A[], Gilbert and Rose-Marie"/>
  <result pre="ByblosLebanonNoureldineHussein A[], Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese" exact="American" post="University, P.O. Box 36, ByblosLebanonChedidGeorges[], Gilbert and Rose-Marie Chagoury"/>
  <result pre="36, ByblosLebanonChedidGeorges[], Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese" exact="American" post="University, P.O. Box 36, ByblosLebanonEldineMariam Nour[], Gilbert and Rose-Marie"/>
  <result pre="ByblosLebanonEldineMariam Nour[], Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese" exact="American" post="University, P.O. Box 36, ByblosLebanonAbdallahDany Abou[], Lebanese University, Faculty"/>
  <result pre="CampusLebanonChedidNancy Falco[], Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese" exact="American" post="University, P.O. Box 36, ByblosLebanonNour-EldineWared[], Gilbert and Rose-Marie Chagoury"/>
  <result pre="36, ByblosLebanonNour-EldineWared[], Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese" exact="American" post="University, P.O. Box 36, ByblosLebanon Corresponding author: Gilbert and"/>
  <result pre="PMC, consistent with existing copyright protections.ftaa033.pdf Abstract ABSTRACT Middle East" exact="Respiratory" post="Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and Coronavirus"/>
  <result pre="consistent with existing copyright protections.ftaa033.pdf Abstract ABSTRACT Middle East Respiratory" exact="Syndrome" post="(MERS), Severe Acute Respiratory Syndrome (SARS) and Coronavirus Disease"/>
  <result pre="existing copyright protections.ftaa033.pdf Abstract ABSTRACT Middle East Respiratory Syndrome (MERS)," exact="Severe" post="Acute Respiratory Syndrome (SARS) and Coronavirus Disease 2019 (COVID-19)"/>
  <result pre="copyright protections.ftaa033.pdf Abstract ABSTRACT Middle East Respiratory Syndrome (MERS), Severe" exact="Acute" post="Respiratory Syndrome (SARS) and Coronavirus Disease 2019 (COVID-19) are"/>
  <result pre="protections.ftaa033.pdf Abstract ABSTRACT Middle East Respiratory Syndrome (MERS), Severe Acute" exact="Respiratory" post="Syndrome (SARS) and Coronavirus Disease 2019 (COVID-19) are caused"/>
  <result pre="Abstract ABSTRACT Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory" exact="Syndrome" post="(SARS) and Coronavirus Disease 2019 (COVID-19) are caused by"/>
  <result pre="Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and Coronavirus" exact="Disease" post="2019 (COVID-19) are caused by three distinct coronaviruses belonging"/>
  <result pre="clinical presentations, and in their propensity for progression to severe" exact="disease" post="which is marked by high rates of morbidity and"/>
  <result pre="rates of morbidity and mortality. However, comparison of the three" exact="viral" post="illnesses also reveals a number of specific differences in"/>
  <result pre="in clinical manifestations and complications, which suggest variability in the" exact="disease" post="process. This narrative review delineates the pulmonary, cardiac, renal,"/>
  <result pre="gastrointestinal, hepatic, neurological and hematologic complications associated with these three" exact="respiratory" post="coronaviruses. It further describes the mechanisms of immune hyperactivationâ€&quot;particularly"/>
  <result pre="or as part of an immune mediated multi-organ failure. severe" exact="acute" post="respiratory syndrome coronavirus 1 Middle East respiratory syndrome coronavirus"/>
  <result pre="as part of an immune mediated multi-organ failure. severe acute" exact="respiratory" post="syndrome coronavirus 1 Middle East respiratory syndrome coronavirus severe"/>
  <result pre="part of an immune mediated multi-organ failure. severe acute respiratory" exact="syndrome" post="coronavirus 1 Middle East respiratory syndrome coronavirus severe acute"/>
  <result pre="multi-organ failure. severe acute respiratory syndrome coronavirus 1 Middle East" exact="respiratory" post="syndrome coronavirus severe acute respiratory syndrome coronavirus 2 coronavirus"/>
  <result pre="failure. severe acute respiratory syndrome coronavirus 1 Middle East respiratory" exact="syndrome" post="coronavirus severe acute respiratory syndrome coronavirus 2 coronavirus disease"/>
  <result pre="respiratory syndrome coronavirus 1 Middle East respiratory syndrome coronavirus severe" exact="acute" post="respiratory syndrome coronavirus 2 coronavirus disease 2019 cytokine release"/>
  <result pre="syndrome coronavirus 1 Middle East respiratory syndrome coronavirus severe acute" exact="respiratory" post="syndrome coronavirus 2 coronavirus disease 2019 cytokine release syndrome"/>
  <result pre="coronavirus 1 Middle East respiratory syndrome coronavirus severe acute respiratory" exact="syndrome" post="coronavirus 2 coronavirus disease 2019 cytokine release syndrome pneumonia"/>
  <result pre="respiratory syndrome coronavirus severe acute respiratory syndrome coronavirus 2 coronavirus" exact="disease" post="2019 cytokine release syndrome pneumonia acute respiratory distress syndrome"/>
  <result pre="acute respiratory syndrome coronavirus 2 coronavirus disease 2019 cytokine release" exact="syndrome" post="pneumonia acute respiratory distress syndrome acute neurologic syndrome central"/>
  <result pre="respiratory syndrome coronavirus 2 coronavirus disease 2019 cytokine release syndrome" exact="pneumonia" post="acute respiratory distress syndrome acute neurologic syndrome central neurogenic"/>
  <result pre="syndrome coronavirus 2 coronavirus disease 2019 cytokine release syndrome pneumonia" exact="acute" post="respiratory distress syndrome acute neurologic syndrome central neurogenic respiratory"/>
  <result pre="coronavirus 2 coronavirus disease 2019 cytokine release syndrome pneumonia acute" exact="respiratory" post="distress syndrome acute neurologic syndrome central neurogenic respiratory failure"/>
  <result pre="coronavirus disease 2019 cytokine release syndrome pneumonia acute respiratory distress" exact="syndrome" post="acute neurologic syndrome central neurogenic respiratory failure heart failure"/>
  <result pre="disease 2019 cytokine release syndrome pneumonia acute respiratory distress syndrome" exact="acute" post="neurologic syndrome central neurogenic respiratory failure heart failure acute"/>
  <result pre="cytokine release syndrome pneumonia acute respiratory distress syndrome acute neurologic" exact="syndrome" post="central neurogenic respiratory failure heart failure acute kidney injury"/>
  <result pre="pneumonia acute respiratory distress syndrome acute neurologic syndrome central neurogenic" exact="respiratory" post="failure heart failure acute kidney injury acute hepatic injury"/>
  <result pre="respiratory distress syndrome acute neurologic syndrome central neurogenic respiratory failure" exact="heart" post="failure acute kidney injury acute hepatic injury page-count: INTRODUCTION"/>
  <result pre="syndrome acute neurologic syndrome central neurogenic respiratory failure heart failure" exact="acute" post="kidney injury acute hepatic injury page-count: INTRODUCTION Coronaviruses have"/>
  <result pre="acute neurologic syndrome central neurogenic respiratory failure heart failure acute" exact="kidney injury" post="acute hepatic injury page-count: INTRODUCTION Coronaviruses have long been"/>
  <result pre="syndrome central neurogenic respiratory failure heart failure acute kidney injury" exact="acute" post="hepatic injury page-count: INTRODUCTION Coronaviruses have long been recognized"/>
  <result pre="Coronaviruses have long been recognized as causative agents in self-limited" exact="upper" post="respiratory tract infections affecting humans (Falsey etÂ al. 1997),"/>
  <result pre="have long been recognized as causative agents in self-limited upper" exact="respiratory" post="tract infections affecting humans (Falsey etÂ al. 1997), however"/>
  <result pre="been recognized as causative agents in self-limited upper respiratory tract" exact="infections" post="affecting humans (Falsey etÂ al. 1997), however three strains"/>
  <result pre="2019, 2020, 2020). These three viruses are the Middle East" exact="Respiratory" post="Syndrome- related virus (MERS-CoV), Severe Acute Respiratory Syndrome- related"/>
  <result pre="viruses are the Middle East Respiratory Syndrome- related virus (MERS-CoV)," exact="Severe" post="Acute Respiratory Syndrome- related virus (SARS CoV-1) and Severe"/>
  <result pre="are the Middle East Respiratory Syndrome- related virus (MERS-CoV), Severe" exact="Acute" post="Respiratory Syndrome- related virus (SARS CoV-1) and Severe Acute"/>
  <result pre="the Middle East Respiratory Syndrome- related virus (MERS-CoV), Severe Acute" exact="Respiratory" post="Syndrome- related virus (SARS CoV-1) and Severe Acute Respiratory"/>
  <result pre="(MERS-CoV), Severe Acute Respiratory Syndrome- related virus (SARS CoV-1) and" exact="Severe" post="Acute Respiratory Syndrome- related virus (SARS CoV-2), also known"/>
  <result pre="Severe Acute Respiratory Syndrome- related virus (SARS CoV-1) and Severe" exact="Acute" post="Respiratory Syndrome- related virus (SARS CoV-2), also known as"/>
  <result pre="Acute Respiratory Syndrome- related virus (SARS CoV-1) and Severe Acute" exact="Respiratory" post="Syndrome- related virus (SARS CoV-2), also known as Coronavirus"/>
  <result pre="Respiratory Syndrome- related virus (SARS CoV-2), also known as Coronavirus" exact="Disease" post="2019- related virus (COVID-19 virus). MERS CoV was first"/>
  <result pre="to be an on ongoing epidemic but appears to be" exact="limited" post="to its area of origin (Al-Tawfiq, Kattan and Memish"/>
  <result pre="National Health Service (NHS) no new cases of SARS CoV-1" exact="infection" post="have been reported in humans since 2004 (National Health"/>
  <result pre="be around 2.3% (Porcheddu etÂ al. 2020). Nonetheless, despite its" exact="lower" post="CFR, COVID-19 has thus far resulted in more deaths"/>
  <result pre="complicationsâ€&quot;with notable variationsâ€&quot;affecting different organ systems (Peeri etÂ al. 2020)." exact="PULMONARY" post="COMPLICATIONS Pneumonia is an extremely common manifestation of these"/>
  <result pre="variationsâ€&quot;affecting different organ systems (Peeri etÂ al. 2020). PULMONARY COMPLICATIONS" exact="Pneumonia" post="is an extremely common manifestation of these three viral"/>
  <result pre="COMPLICATIONS Pneumonia is an extremely common manifestation of these three" exact="viral" post="diseases. It typically follows the initial presentation of a"/>
  <result pre="COVID-19 hospitalized patients in an early cohort from Wuhan developed" exact="pneumonia" post="(Huang etÂ al. 2020). In COVID-19, this pneumonia appears"/>
  <result pre="Wuhan developed pneumonia (Huang etÂ al. 2020). In COVID-19, this" exact="pneumonia" post="appears to predict poor outcome; 25.9% (72/278) of patients"/>
  <result pre="outcome; 25.9% (72/278) of patients in a pooled cohort with" exact="pneumonia" post="were admitted to an intensive care unit (ICU) (Lai"/>
  <result pre="COVID-19 can be variable, ranging from no symptoms to mild" exact="upper respiratory tract infection" post="to respiratory failure (Zhou etÂ al. 2020), upper respiratory"/>
  <result pre="can be variable, ranging from no symptoms to mild upper" exact="respiratory" post="tract infection to respiratory failure (Zhou etÂ al. 2020),"/>
  <result pre="variable, ranging from no symptoms to mild upper respiratory tract" exact="infection" post="to respiratory failure (Zhou etÂ al. 2020), upper respiratory"/>
  <result pre="from no symptoms to mild upper respiratory tract infection to" exact="respiratory" post="failure (Zhou etÂ al. 2020), upper respiratory symptoms appear"/>
  <result pre="respiratory tract infection to respiratory failure (Zhou etÂ al. 2020)," exact="upper" post="respiratory symptoms appear infrequently in MERS (Arabi etÂ al."/>
  <result pre="tract infection to respiratory failure (Zhou etÂ al. 2020), upper" exact="respiratory" post="symptoms appear infrequently in MERS (Arabi etÂ al. 2014)."/>
  <result pre="recover from his/her initial illness before rapidly deteriorating (new fever," exact="chest" post="infiltrates, respiratory failure and watery diarrhea) a few days"/>
  <result pre="his/her initial illness before rapidly deteriorating (new fever, chest infiltrates," exact="respiratory" post="failure and watery diarrhea) a few days later (Sampathkumar"/>
  <result pre="later (Sampathkumar etÂ al. 2003). The first phase corresponds to" exact="viral" post="replication and is marked by fever, myalgia and systemic"/>
  <result pre="to viral replication and is marked by fever, myalgia and" exact="systemic" post="symptoms, while the second phase reflects immune-mediated lung damage"/>
  <result pre="phase reflects immune-mediated lung damage coinciding with a decrease in" exact="viral" post="load (Hui, Wong and Wang 2003); this phased course"/>
  <result pre="and Wang 2003); this phased course may be explained by" exact="acute" post="respiratory distress syndrome (ARDS)-like pathophysiology (discussed below). ARDS is"/>
  <result pre="Wang 2003); this phased course may be explained by acute" exact="respiratory" post="distress syndrome (ARDS)-like pathophysiology (discussed below). ARDS is seen"/>
  <result pre="this phased course may be explained by acute respiratory distress" exact="syndrome" post="(ARDS)-like pathophysiology (discussed below). ARDS is seen fairly often"/>
  <result pre="Figure 1. Proposed model of pathophysiological mechanisms underlying cytokine release" exact="syndrome" post="(CRS) and possible therapeutic interventions. CRS begins with binding"/>
  <result pre="upregulate the expression of adhesion molecules (ICAM-1, VCAM-1, E-selectin), increase" exact="vascular" post="permeability and induce leukocyte recruitment. (c) Plasmacytoid dendritic cells"/>
  <result pre="(c) Plasmacytoid dendritic cells (pDCs), on the other hand, secrete" exact="Type I" post="interferon, to inhibit viral replication and synthesis of viral"/>
  <result pre="on the other hand, secrete Type I interferon, to inhibit" exact="viral" post="replication and synthesis of viral proteins and educate naÃ¯ve"/>
  <result pre="Type I interferon, to inhibit viral replication and synthesis of" exact="viral" post="proteins and educate naÃ¯ve T cells (Th0) in the"/>
  <result pre="of additional cytokines: IL-6, IL-1Î² and TNF-a further contributing to" exact="systemic" post="toxicity. (h) IL-6 and IL-1b act on the hypothalamus"/>
  <result pre="(Lenizulumab) act as potential therapeutics. Hydroxychloroquine (HCQ) can interfere with" exact="viral" post="entry and replication; and can also inhibit immune cell"/>
  <result pre="IL-17, interleukin 17; IL-10, interleukin 10; IL-1b, interleukin 1beta; TNF-a," exact="tumor" post="necrosis factor alpha; TGF-b, transforming growth factor beta; IFN-g,"/>
  <result pre="factor alpha; TGF-b, transforming growth factor beta; IFN-g, interferon gamma;" exact="Type I" post="IFN, Type I interferon; ROS, reactive oxygen species; ICAM-1,"/>
  <result pre="transforming growth factor beta; IFN-g, interferon gamma; Type I IFN," exact="Type I" post="interferon; ROS, reactive oxygen species; ICAM-1, intercellular adhesion molecule;"/>
  <result pre="interferon; ROS, reactive oxygen species; ICAM-1, intercellular adhesion molecule; VCAM-1," exact="vascular" post="cellular adhesion molecules; GM-CSF, granulocyte monocyte colony stimulating factor;"/>
  <result pre="intercellular adhesion molecule; VCAM-1, vascular cellular adhesion molecules; GM-CSF, granulocyte" exact="monocyte" post="colony stimulating factor; Th1, T helper subset 1; Th17,"/>
  <result pre="Th17, T helper subset 17; Th0, naÃ¯ve T cells; TNFR-Ig," exact="tumor" post="necrosis factor alpha receptor-immunoglobulin fusion protein; SARS-CoV-2, severe acute"/>
  <result pre="TNFR-Ig, tumor necrosis factor alpha receptor-immunoglobulin fusion protein; SARS-CoV-2, severe" exact="acute" post="respiratory syndrome coronavirus 2; HCQ, Hydroxychloroquine. On autopsy, lung"/>
  <result pre="tumor necrosis factor alpha receptor-immunoglobulin fusion protein; SARS-CoV-2, severe acute" exact="respiratory" post="syndrome coronavirus 2; HCQ, Hydroxychloroquine. On autopsy, lung findings"/>
  <result pre="necrosis factor alpha receptor-immunoglobulin fusion protein; SARS-CoV-2, severe acute respiratory" exact="syndrome" post="coronavirus 2; HCQ, Hydroxychloroquine. On autopsy, lung findings post-ARDS"/>
  <result pre="the three diseases (Xu etÂ al. 2020). Common features include" exact="epithelial" post="desquamation and regeneration, and diffuse alveolar damage, possibly due"/>
  <result pre="al. 2020). Common features include epithelial desquamation and regeneration, and" exact="diffuse" post="alveolar damage, possibly due to direct damage from the"/>
  <result pre="suffer clinical deterioration in the phased manner typical of this" exact="disease" post="often show bilateral lung involvement that resembles ARDS on"/>
  <result pre="in the phased manner typical of this disease often show" exact="bilateral" post="lung involvement that resembles ARDS on radiologic imaging seen"/>
  <result pre="possible that an interferon-gamma (IFN-Î³) mediated cytokine storm after SARS" exact="infection" post="is the culprit (Huang etÂ al. 2005). In fact,"/>
  <result pre="until the third week of a SARS infection, whereas peak" exact="viral" post="loads are observed around day 10 (Sampathkumar etÂ al."/>
  <result pre="etÂ al. 2014), which resemble those of SARS-ARDS (acute hypoxemic" exact="respiratory" post="failure) (Arabi etÂ al. 2014). Curiously, all 12 members"/>
  <result pre="in Saudi Arabia who developed ARDS suffered from comorbidities (asthma," exact="diabetes mellitus," post="renal failure and others), suggesting that ARDS tends to"/>
  <result pre="Arabia who developed ARDS suffered from comorbidities (asthma, diabetes mellitus," exact="renal failure" post="and others), suggesting that ARDS tends to manifest more"/>
  <result pre="often in susceptible patients (Arabi etÂ al. 2014). CARDIAC COMPLICATION" exact="Heart" post="problems have been reported fairly frequently, at least among"/>
  <result pre="11 of them (15.7%) developed arrhythmia, and 10 (14.3%) developed" exact="rhabdomyolysis" post="(Saad etÂ al. 2014) (it is unclear if the"/>
  <result pre="rhabdomyolysis (Saad etÂ al. 2014) (it is unclear if the" exact="arrhythmia" post="and rhabdomyolysis were related). Among COVID-19 patients, heart problems"/>
  <result pre="etÂ al. 2014) (it is unclear if the arrhythmia and" exact="rhabdomyolysis" post="were related). Among COVID-19 patients, heart problems also seem"/>
  <result pre="if the arrhythmia and rhabdomyolysis were related). Among COVID-19 patients," exact="heart" post="problems also seem fairly prevalent; acute cardiac injury or"/>
  <result pre="related). Among COVID-19 patients, heart problems also seem fairly prevalent;" exact="acute" post="cardiac injury or elevated cardiac enzymes were reported in"/>
  <result pre="day 14 in survivors (Zhou etÂ al. 2020). In addition," exact="heart" post="failure was reported in 44 out of a group"/>
  <result pre="group of 191 (23%) COVID-19 patients (PÂ etÂ al. 2020)." exact="RENAL" post="COMPLICATIONS Kidney damage, especially acute kidney injury (AKI), appears"/>
  <result pre="191 (23%) COVID-19 patients (PÂ etÂ al. 2020). RENAL COMPLICATIONS" exact="Kidney" post="damage, especially acute kidney injury (AKI), appears to be"/>
  <result pre="patients (PÂ etÂ al. 2020). RENAL COMPLICATIONS Kidney damage, especially" exact="acute" post="kidney injury (AKI), appears to be frequent in the"/>
  <result pre="(PÂ etÂ al. 2020). RENAL COMPLICATIONS Kidney damage, especially acute" exact="kidney injury" post="(AKI), appears to be frequent in the context of"/>
  <result pre="therapy (Arabi etÂ al. 2014). Arabi and coworkers have noted" exact="lower" post="rates of AKI in the context of MERS in"/>
  <result pre="investigators suggested the possibility of direct renal involvement by the" exact="viral infection," post="as MERS can be isolated from the urine of"/>
  <result pre="be isolated from the urine of affected patients. In COVID-19," exact="kidney damage" post="is reported in as few as in 2.5% of"/>
  <result pre="AKI in 28/191 (15%; PÂ etÂ al. 2020). GASTROINTESTINAL COMPLICATIONS" exact="Nonspecific" post="gastrointestinal symptoms are commonly reported. Diarrhea, nausea and a"/>
  <result pre="SARS patients (Leung etÂ al. 2003). Among SARS patients, watery" exact="diarrhea" post="was most often reported in the first week of"/>
  <result pre="often reported in the first week of illness, and the" exact="diarrhea" post="did not correlate with mortality or subsequent requirement for"/>
  <result pre="oxygen (Leung etÂ al. 2003); furthermore, Leung and coworkers detected" exact="viral" post="particles on biopsy of the small intestine and colon"/>
  <result pre="small intestine and colon (Leung etÂ al. 2003). HEPATIC COMPLICATIONS" exact="Acute" post="hepatic injury has been reported, most often in MERS."/>
  <result pre="it should be further noted that this proportion was even" exact="lower" post="than that in Wuhan (Wu etÂ al. 2020). NEUROLOGIC"/>
  <result pre="even lower than that in Wuhan (Wu etÂ al. 2020)." exact="NEUROLOGIC" post="COMPLICATIONS Acute neurologic syndromes have been reported in both"/>
  <result pre="than that in Wuhan (Wu etÂ al. 2020). NEUROLOGIC COMPLICATIONS" exact="Acute" post="neurologic syndromes have been reported in both SARS and"/>
  <result pre="evolving. An early report described a SARS patient who developed" exact="respiratory" post="failure and status epilepticus several days after mounting a"/>
  <result pre="report described a SARS patient who developed respiratory failure and" exact="status epilepticus" post="several days after mounting a fever; SARS-CoV RNA was"/>
  <result pre="RNA was detected in her cerebrospinal fluid (CSF), suggesting a" exact="demyelinating disease" post="process (Hung etÂ al. 2003). Another case described a"/>
  <result pre="was detected in her cerebrospinal fluid (CSF), suggesting a demyelinating" exact="disease" post="process (Hung etÂ al. 2003). Another case described a"/>
  <result pre="Another case described a pregnant woman who suffered from generalized" exact="tonic-clonic" post="seizures on day 22 of a SARS infection; RT-PCR"/>
  <result pre="case described a pregnant woman who suffered from generalized tonic-clonic" exact="seizures" post="on day 22 of a SARS infection; RT-PCR for"/>
  <result pre="was positive, even though CSF parameters were normal, and no" exact="focal" post="neurologic deficits were observed (Lau etÂ al. 2004). MERS"/>
  <result pre="and pathophysiology seem to differ from those associated with SARS." exact="Seizures" post="were reported in 6/70 patients (8.6%) in a Saudi"/>
  <result pre="severe neurologic symptoms. These patients presented with altered consciousness, coma," exact="ataxia" post="and focal motor deficits. On magnetic resonance imaging (MRI),"/>
  <result pre="symptoms. These patients presented with altered consciousness, coma, ataxia and" exact="focal motor" post="deficits. On magnetic resonance imaging (MRI), T2-weighted images showed"/>
  <result pre="deficits. On magnetic resonance imaging (MRI), T2-weighted images showed non-enhancing" exact="bilateral" post="hyperintense lesions in white matter and in subcortical regions"/>
  <result pre="lobes. Arabi et al did not report virus detection in" exact="brain" post="tissue or CSF but noted that the disease process"/>
  <result pre="detection in brain tissue or CSF but noted that the" exact="disease" post="process resembled acute disseminated encephalomyelitis, or non-occlusive stroke via"/>
  <result pre="tissue or CSF but noted that the disease process resembled" exact="acute" post="disseminated encephalomyelitis, or non-occlusive stroke via MERS vasculopathy (Arabi"/>
  <result pre="that the disease process resembled acute disseminated encephalomyelitis, or non-occlusive" exact="stroke" post="via MERS vasculopathy (Arabi etÂ al. 2015). The possibility"/>
  <result pre="vasculopathy (Arabi etÂ al. 2015). The possibility of central neurogenic" exact="respiratory" post="failure in the setting of coronavirus infection is supported"/>
  <result pre="of central neurogenic respiratory failure in the setting of coronavirus" exact="infection" post="is supported by some evidence from animal models (Li"/>
  <result pre="Angiotensin converting enzyme-2 (ACE2) receptors that could efficiently bind SARS-CoV-1" exact="viral" post="particles, to establish that SARS-CoV-1 particles could enter the"/>
  <result pre="viral particles, to establish that SARS-CoV-1 particles could enter the" exact="brain" post="via intranasal inoculation. The infection propagated from the sinuses"/>
  <result pre="SARS-CoV-1 particles could enter the brain via intranasal inoculation. The" exact="infection" post="propagated from the sinuses to the olfactory bulb. Once"/>
  <result pre="propagated from the sinuses to the olfactory bulb. Once the" exact="infection" post="of the olfactory bulb was established, the infection spread"/>
  <result pre="Once the infection of the olfactory bulb was established, the" exact="infection" post="spread throughout the brain to reach the medullary respiratory"/>
  <result pre="the olfactory bulb was established, the infection spread throughout the" exact="brain" post="to reach the medullary respiratory center; consequently, these mice"/>
  <result pre="established, the infection spread throughout the brain to reach the" exact="medullary" post="respiratory center; consequently, these mice died from central respiratory"/>
  <result pre="the infection spread throughout the brain to reach the medullary" exact="respiratory" post="center; consequently, these mice died from central respiratory failure."/>
  <result pre="the medullary respiratory center; consequently, these mice died from central" exact="respiratory" post="failure. Interestingly, the lungs of the mice showed minimal"/>
  <result pre="pathological changes, and the initial concentration of ACE2 receptors in" exact="brain" post="tissue was only 1% of their concentration in lung"/>
  <result pre="their concentration in lung tissue. In this experiment, establishing an" exact="infection" post="of the sinuses may have been essential because hematogenous"/>
  <result pre="sinuses may have been essential because hematogenous spread to the" exact="brain" post="is unlikely (Ding etÂ al. 2004). Similarly, Li etÂ"/>
  <result pre="could occur once mice were inoculated with MERS-CoV intranasally; the" exact="infection" post="showed a predilection for the thalamus and brainstem (the"/>
  <result pre="predilection for the thalamus and brainstem (the latter containing the" exact="respiratory" post="center; Li etÂ al. 2016). Until now, there have"/>
  <result pre="been no studies demonstrating SARS-CoV-2 involvement in damage to the" exact="respiratory" post="centers. However, presentation with such an entity would merit"/>
  <result pre="thorough investigation, due to its complex involvement of both the" exact="peripheral" post="components and the central neurologic components of the respiratory"/>
  <result pre="the peripheral components and the central neurologic components of the" exact="respiratory" post="system. Furthermore, several multicentric cohort studies demonstrated associations between"/>
  <result pre="in SARS-CoV-1-positive mice or to any direct insult to the" exact="central nervous system." post="Instead it has been attributed to non-neural cell expression"/>
  <result pre="to non-neural cell expression of SARS-CoV-2 entry genes in the" exact="respiratory" post="epithelium (Brann etÂ al. 2020), a finding which has"/>
  <result pre="of COVID-1941. As with anosmia, dysgeusia was more prevalent among" exact="female" post="patients with COVID-19 than male patients, in a multi-center"/>
  <result pre="noted in 54/54 (100%) of non-survivors in one cohort, and" exact="septic shock" post="in 38/54 (70%) of non-survivors (PÂ etÂ al. 2020)."/>
  <result pre="indication for anti-coagulant use (Connors and Levy 2020). Indeed, COVID-19" exact="coagulopathy" post="is likely to present with elevated D-dimer and fibrin/fibrinogen"/>
  <result pre="and fibrin/fibrinogen products in the setting of normal prothrombin time," exact="partial" post="thromboplastin time and platelet counts (Connors and Levy 2020);"/>
  <result pre="and Levy 2020); these findings may appear in early COVID-19" exact="infection" post="even when there is no clinically identifiable bleeding. Interestingly,"/>
  <result pre="is no clinically identifiable bleeding. Interestingly, the pathophysiology of SARS-CoV-2-induced" exact="coagulopathy" post="may be linked to the receptor of viral adhesion,"/>
  <result pre="of SARS-CoV-2-induced coagulopathy may be linked to the receptor of" exact="viral" post="adhesion, the ACE2 receptor, which is abundant on vascular"/>
  <result pre="of viral adhesion, the ACE2 receptor, which is abundant on" exact="vascular" post="endothelial cells â€&quot; and thus may facilitate endothelial dysfunction"/>
  <result pre="cells â€&quot; and thus may facilitate endothelial dysfunction and further" exact="coagulopathy" post="in COVID-19 infections (Varga etÂ al. 2020). Reports of"/>
  <result pre="thus may facilitate endothelial dysfunction and further coagulopathy in COVID-19" exact="infections" post="(Varga etÂ al. 2020). Reports of SARS-CoV-2 viral inclusions"/>
  <result pre="in COVID-19 infections (Varga etÂ al. 2020). Reports of SARS-CoV-2" exact="viral" post="inclusions in endothelial cells in postmortem studies (Varga etÂ"/>
  <result pre="mechanism of viral-mediated direct endothelial insult, inflammatory mediators of COVID-19" exact="infection" post="may have a pivotal role in the pathogenesis of"/>
  <result pre="infection may have a pivotal role in the pathogenesis of" exact="coagulopathy" post="(Jose and Manuel 2020). This interplay between the inflammatory"/>
  <result pre="the passage below. CYTOKINE RELEASE SYNDROME: AN IMMUNE ETIOLOGY FOR" exact="MULTIPLE" post="ORGAN FAILURE Cytokine-release syndrome (CRS) also known as cytokine"/>
  <result pre="RELEASE SYNDROME: AN IMMUNE ETIOLOGY FOR MULTIPLE ORGAN FAILURE Cytokine-release" exact="syndrome" post="(CRS) also known as cytokine storm, is the excessive"/>
  <result pre="agents used to target specific malignancies (Rotz etÂ al. 2017)." exact="Elevated" post="Interleukin-6 (IL-6) and Interleukin-10 (IL-10) values have been described"/>
  <result pre="other cytokines such as Interferon-gamma (IFN- Î³), Interleukin-1 (IL-1) and" exact="tumor" post="necrosis factor alpha (TNF- Î±) were also found to"/>
  <result pre="values of IL-6 and IL-10 and increased severity of the" exact="disease" post="(Qin etÂ al. 2020; Wan etÂ al. 2020). While"/>
  <result pre="CRS may be an inflammatory etiology for increased risk of" exact="coagulopathy" post="in COVID-19 patients. CRS prerogative state is also characterized"/>
  <result pre="patients. CRS prerogative state is also characterized by disseminated intravascular" exact="coagulopathy" post="leading to multi-organ failure (figure 1) (Tang etÂ al."/>
  <result pre="neurological manifestations previously discussed. Another recognized immune hyperactivation mechanism is" exact="secondary" post="hemophagocytic lymphohistiocytosis (sHLH). The pathophysiology of sHLH is conceived"/>
  <result pre="manifestations previously discussed. Another recognized immune hyperactivation mechanism is secondary" exact="hemophagocytic lymphohistiocytosis" post="(sHLH). The pathophysiology of sHLH is conceived as a"/>
  <result pre="sHLH has commonly been described in the setting of underlying" exact="disease" post="states such as malignancies, autoimmune conditions and viral infections"/>
  <result pre="in the setting of underlying disease states such as malignancies," exact="autoimmune" post="conditions and viral infections (Ramos-Casals etÂ al. 2014). Of"/>
  <result pre="of underlying disease states such as malignancies, autoimmune conditions and" exact="viral" post="infections (Ramos-Casals etÂ al. 2014). Of note, the cytokine"/>
  <result pre="underlying disease states such as malignancies, autoimmune conditions and viral" exact="infections" post="(Ramos-Casals etÂ al. 2014). Of note, the cytokine profile"/>
  <result pre="role in the pathophysiology of the disease. Decreased levels of" exact="peripheral" post="CD4 and CD8 T cells have been observed, yet"/>
  <result pre="al. 2014). Moreover, patients with elevated IL-17 experienced more severe" exact="disease" post="(Faure etÂ al. 2014). CRS, sHLH and T-cell dysregulation"/>
  <result pre="and T-cell dysregulation all have been reported to cause interstitial" exact="pulmonary" post="inflammation and ARDS, among other types of organ-system dysfunction"/>
  <result pre="etÂ al. 2020). In addition, lung damage related to COVID-19" exact="infection" post="has been associated with lymphocytic infiltrates, thus providing evidence"/>
  <result pre="MERS patients (Hong etÂ al. 2018). However, other reports stop" exact="short" post="of endorsing a definitive role for CRS in disease"/>
  <result pre="stop short of endorsing a definitive role for CRS in" exact="disease" post="severity, since no studies have described a direct link"/>
  <result pre="may be advisable to screen all COVID-19 patients with severe" exact="disease" post="for hyper-inflammatory responses, using laboratory trends such as increasing"/>
  <result pre="al. 2014), which are similar to trends associated with COVID-19" exact="coagulopathy" post="(Connors and Levy 2020). Radiological findings from different cohort"/>
  <result pre="2020) were similar to those characterizing lung damage caused by" exact="autoimmune" post="and autoinflammatory diseases (Saper etÂ al. 2019). This similarity"/>
  <result pre="decreasing the symptoms of immune-related toxicity from anti-PD-1 agents in" exact="cancer" post="patients including CRS (Horisberger etÂ al. 2018; Stroud etÂ"/>
  <result pre="This malaria-prophylaxis drug, previously proven effective in the treatment of" exact="autoimmune diseases" post="such as systemic lupus erythematous (SLE; PAGE 1951; Ben-Zvi"/>
  <result pre="proven effective in the treatment of autoimmune diseases such as" exact="systemic" post="lupus erythematous (SLE; PAGE 1951; Ben-Zvi etÂ al. 2012)"/>
  <result pre="effective in the treatment of autoimmune diseases such as systemic" exact="lupus" post="erythematous (SLE; PAGE 1951; Ben-Zvi etÂ al. 2012) was"/>
  <result pre="resulting evidence for its efficacy in the treatment of COVID-19" exact="infection" post="was contradictory: Results from some trials suggested that hydroxychloroquine"/>
  <result pre="from some trials suggested that hydroxychloroquine is effective in facilitating" exact="viral" post="elimination and decreasing time to recovery (Chen etÂ al."/>
  <result pre="2020; Gautret etÂ al. 2020). However, these trials included a" exact="limited" post="number of patients, most of whom were mildly symptomatic."/>
  <result pre="effects. CONCLUSION MERS, SARS AND COVID-19 are all identified as" exact="respiratory" post="viruses. Nevertheless, they exhibit systemic complications and complications specific"/>
  <result pre="COVID-19 are all identified as respiratory viruses. Nevertheless, they exhibit" exact="systemic" post="complications and complications specific to other organ systems, especially"/>
  <result pre="instructive, vital for appropriate patient management, and suggestive of various" exact="disease" post="mechanisms that may be targeted through the development of"/>
  <result pre="of interest None References REFERENCES AjlanAM, AhyadRA, JamjoomLGet al.Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) infection: chest CT findings. AJR Am"/>
  <result pre="interest None References REFERENCES AjlanAM, AhyadRA, JamjoomLGet al.Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) infection: chest CT findings. AJR Am J"/>
  <result pre="AjlanAM, AhyadRA, JamjoomLGet al.Middle East respiratory syndrome coronavirus (MERS-CoV) infection:" exact="chest" post="CT findings. AJR Am J Roentgenol. 2014;203:782â€&quot;7.24918624 Al-TawfiqJA, KattanRF,"/>
  <result pre="findings. AJR Am J Roentgenol. 2014;203:782â€&quot;7.24918624 Al-TawfiqJA, KattanRF, MemishZAMiddle East" exact="respiratory" post="syndrome coronavirus disease is rare in children: an update"/>
  <result pre="AJR Am J Roentgenol. 2014;203:782â€&quot;7.24918624 Al-TawfiqJA, KattanRF, MemishZAMiddle East respiratory" exact="syndrome" post="coronavirus disease is rare in children: an update from"/>
  <result pre="J Roentgenol. 2014;203:782â€&quot;7.24918624 Al-TawfiqJA, KattanRF, MemishZAMiddle East respiratory syndrome coronavirus" exact="disease" post="is rare in children: an update from Saudi Arabia."/>
  <result pre="course and outcomes of critically ill patients with Middle East" exact="respiratory" post="syndrome coronavirus infection. Ann Intern Med. 2014;160:389â€&quot;97.24474051 ArabiYM, HarthiA,"/>
  <result pre="and outcomes of critically ill patients with Middle East respiratory" exact="syndrome" post="coronavirus infection. Ann Intern Med. 2014;160:389â€&quot;97.24474051 ArabiYM, HarthiA, HusseinJet"/>
  <result pre="infection. Ann Intern Med. 2014;160:389â€&quot;97.24474051 ArabiYM, HarthiA, HusseinJet al.Severe neurologic" exact="syndrome" post="associated with Middle East respiratory syndrome corona virus (MERS-CoV)."/>
  <result pre="ArabiYM, HarthiA, HusseinJet al.Severe neurologic syndrome associated with Middle East" exact="respiratory" post="syndrome corona virus (MERS-CoV). Infection. 2015;43:495â€&quot;501.25600929 BaasT, TaubenbergerJK, ChongPYet"/>
  <result pre="HarthiA, HusseinJet al.Severe neurologic syndrome associated with Middle East respiratory" exact="syndrome" post="corona virus (MERS-CoV). Infection. 2015;43:495â€&quot;501.25600929 BaasT, TaubenbergerJK, ChongPYet al.SARS-CoV"/>
  <result pre="BaasT, TaubenbergerJK, ChongPYet al.SARS-CoV virus-host interactions and comparative etiologies of" exact="acute" post="respiratory distress syndrome as determined by transcriptional and cytokine"/>
  <result pre="TaubenbergerJK, ChongPYet al.SARS-CoV virus-host interactions and comparative etiologies of acute" exact="respiratory" post="distress syndrome as determined by transcriptional and cytokine profiling"/>
  <result pre="al.SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress" exact="syndrome" post="as determined by transcriptional and cytokine profiling of formalin-fixed"/>
  <result pre="tissues. J Interferon Cytokine Res. 2006;26:309â€&quot;17.16689659 BanikGR, KhandakerG, RashidHMiddle East" exact="respiratory" post="syndrome coronavirus â€œMERS-CoVâ€�: current knowledge gaps. Paediatr Respir Rev."/>
  <result pre="J Interferon Cytokine Res. 2006;26:309â€&quot;17.16689659 BanikGR, KhandakerG, RashidHMiddle East respiratory" exact="syndrome" post="coronavirus â€œMERS-CoVâ€�: current knowledge gaps. Paediatr Respir Rev. 2015;16:197â€&quot;202.26002405"/>
  <result pre="gaps. Paediatr Respir Rev. 2015;16:197â€&quot;202.26002405 Ben-ZviI, KivityS, LangevitzPet al.Hydroxychloroquine: from" exact="malaria" post="to autoimmunity. Clin Rev Allergy Immunol. 2012;42:145â€&quot;53.21221847 BrannDH, TsukaharaT,"/>
  <result pre="in the research of cytokine storm mechanism induced by Corona" exact="Virus Disease" post="2019 and the corresponding immunotherapies). Zhonghua Shao Shang Za"/>
  <result pre="the research of cytokine storm mechanism induced by Corona Virus" exact="Disease" post="2019 and the corresponding immunotherapies). Zhonghua Shao Shang Za"/>
  <result pre="trial. MedRxiv. 2020, 10.1101/2020.03.22.20040758. ConnorsJ, LevyJCOVID-19 and its implications for" exact="thrombosis" post="and anticoagulation. Blood. 2020;135:2033â€&quot;40.32339221 DescotesJ, VialTFlu-like syndrome and cytokines."/>
  <result pre="its implications for thrombosis and anticoagulation. Blood. 2020;135:2033â€&quot;40.32339221 DescotesJ, VialTFlu-like" exact="syndrome" post="and cytokines. Cytokines in Human Health. Totowa, New Jersey:"/>
  <result pre="Springer; 2007, 193â€&quot;204. DingY, HeL, ZhangQet al.Organ distribution of severe" exact="acute" post="respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients:"/>
  <result pre="2007, 193â€&quot;204. DingY, HeL, ZhangQet al.Organ distribution of severe acute" exact="respiratory" post="syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications"/>
  <result pre="193â€&quot;204. DingY, HeL, ZhangQet al.Organ distribution of severe acute respiratory" exact="syndrome" post="(SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for"/>
  <result pre="HScore, a score for the diagnosis of reactive hemophagocytic syndrome." exact="Arthritis" post="Rheumatol. 2014;66:2613â€&quot;20.24782338 FaureE, PoissyJ, GoffardAet al.Distinct immune response in"/>
  <result pre="2020;0:48:105949. HongKH, ChoiJP, HongSHet al.Predictors of mortality in Middle East" exact="respiratory" post="syndrome (MERS). Thorax. 2018;73:286â€&quot;9.28724637 HorisbergerA, LaÂ RosaS, ZurcherJPet al.A"/>
  <result pre="HongKH, ChoiJP, HongSHet al.Predictors of mortality in Middle East respiratory" exact="syndrome" post="(MERS). Thorax. 2018;73:286â€&quot;9.28724637 HorisbergerA, LaÂ RosaS, ZurcherJPet al.A severe"/>
  <result pre="HorisbergerA, LaÂ RosaS, ZurcherJPet al.A severe case of refractory esophageal" exact="stenosis" post="induced by nivolumab and responding to tocilizumab therapy. J"/>
  <result pre="RNA in the cerebrospinal fluid of a patient with severe" exact="acute" post="respiratory syndrome. Clin Chem. 2003;49:2108â€&quot;9.14633896 JiangF, DengL, ZhangLet al.Review"/>
  <result pre="in the cerebrospinal fluid of a patient with severe acute" exact="respiratory" post="syndrome. Clin Chem. 2003;49:2108â€&quot;9.14633896 JiangF, DengL, ZhangLet al.Review of"/>
  <result pre="JiangF, DengL, ZhangLet al.Review of the clinical characteristics of coronavirus" exact="disease" post="2019 (COVID-19). J Gen Intern Med. 2020;35:1545â€&quot;9.32133578 JoseRJ, ManuelACOVID-19"/>
  <result pre="Respir Med. 2020;8. JossetL, MenacheryVD, GralinskiLEet al.Cell host response to" exact="infection" post="with novel human coronavirus EMC predicts potential antivirals and"/>
  <result pre="SARS coronavirus. mBio. 2013;4:e00165â€&quot;13.23631916 JosÃ©R, WilliamsA, ChambersRProteinase-activated receptors in fibroproliferative" exact="lung disease." post="Thorax. 2014;69:190â€&quot;2.24186921 LaiC-C, ShihT-P, KoW-Cet al.Severe acute respiratory syndrome"/>
  <result pre="in fibroproliferative lung disease. Thorax. 2014;69:190â€&quot;2.24186921 LaiC-C, ShihT-P, KoW-Cet al.Severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19):"/>
  <result pre="fibroproliferative lung disease. Thorax. 2014;69:190â€&quot;2.24186921 LaiC-C, ShihT-P, KoW-Cet al.Severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the"/>
  <result pre="lung disease. Thorax. 2014;69:190â€&quot;2.24186921 LaiC-C, ShihT-P, KoW-Cet al.Severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic"/>
  <result pre="challenges. Int J Antimicrob Agents. 2020;55:105924.32081636 LauKK, YuWC, ChuCMet al.Possible" exact="central nervous system" post="infection by SARS coronavirus. Emerg Infect Dis. 2004;10:342â€&quot;4.15030709 LechienJ,"/>
  <result pre="Antimicrob Agents. 2020;55:105924.32081636 LauKK, YuWC, ChuCMet al.Possible central nervous system" exact="infection" post="by SARS coronavirus. Emerg Infect Dis. 2004;10:342â€&quot;4.15030709 LechienJ, Chiesa-EstombaC,"/>
  <result pre="as a clinical presentation of mild-to-moderate forms of the coronavirus" exact="disease" post="(COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277:2251â€&quot;61.32253535"/>
  <result pre="Arch Otorhinolaryngol. 2020;277:2251â€&quot;61.32253535 LeungWK, ToKF, ChanPKet al.Enteric involvement of severe" exact="acute" post="respiratory syndrome-associated coronavirus infection. Gastroenterology. 2003;125:1011â€&quot;7.14517783 LiK, Wohlford-LenaneC, PerlmanSet"/>
  <result pre="Otorhinolaryngol. 2020;277:2251â€&quot;61.32253535 LeungWK, ToKF, ChanPKet al.Enteric involvement of severe acute" exact="respiratory" post="syndrome-associated coronavirus infection. Gastroenterology. 2003;125:1011â€&quot;7.14517783 LiK, Wohlford-LenaneC, PerlmanSet al.Middle"/>
  <result pre="syndrome-associated coronavirus infection. Gastroenterology. 2003;125:1011â€&quot;7.14517783 LiK, Wohlford-LenaneC, PerlmanSet al.Middle East" exact="respiratory" post="syndrome coronavirus causes multiple organ damage and lethal disease"/>
  <result pre="coronavirus infection. Gastroenterology. 2003;125:1011â€&quot;7.14517783 LiK, Wohlford-LenaneC, PerlmanSet al.Middle East respiratory" exact="syndrome" post="coronavirus causes multiple organ damage and lethal disease in"/>
  <result pre="East respiratory syndrome coronavirus causes multiple organ damage and lethal" exact="disease" post="in mice transgenic for human dipeptidyl peptidase 4. J"/>
  <result pre="neuroinvasive potential of SARS-CoV2 may play a role in the" exact="respiratory" post="failure of COVID-19 patients. J Med Virol. 2020;92:552â€&quot;5.32104915 MahaseECoronavirus:"/>
  <result pre="has killed more people than SARS and MERS combined, despite" exact="lower" post="case fatality rate. BMJ. 2020;368:m641.32071063 MajumderMS, RiversC, LofgrenEet al.Estimation"/>
  <result pre="2014;6. MizumotoK, SaitohM, ChowellGet al.Estimating the risk of Middle East" exact="respiratory" post="syndrome (MERS) death during the course of the outbreak"/>
  <result pre="MizumotoK, SaitohM, ChowellGet al.Estimating the risk of Middle East respiratory" exact="syndrome" post="(MERS) death during the course of the outbreak in"/>
  <result pre="infection. Med Mal Infect. 2020;50:384.32240719 collab: National Health ServiceSARS (severe" exact="acute" post="respiratory syndrome), National Health Service2019, October 24. NetlandJ, MeyerholzDK,"/>
  <result pre="Med Mal Infect. 2020;50:384.32240719 collab: National Health ServiceSARS (severe acute" exact="respiratory" post="syndrome), National Health Service2019, October 24. NetlandJ, MeyerholzDK, MooreSet"/>
  <result pre="syndrome), National Health Service2019, October 24. NetlandJ, MeyerholzDK, MooreSet al.Severe" exact="acute" post="respiratory syndrome coronavirus infection causes neuronal death in the"/>
  <result pre="National Health Service2019, October 24. NetlandJ, MeyerholzDK, MooreSet al.Severe acute" exact="respiratory" post="syndrome coronavirus infection causes neuronal death in the absence"/>
  <result pre="Health Service2019, October 24. NetlandJ, MeyerholzDK, MooreSet al.Severe acute respiratory" exact="syndrome" post="coronavirus infection causes neuronal death in the absence of"/>
  <result pre="October 24. NetlandJ, MeyerholzDK, MooreSet al.Severe acute respiratory syndrome coronavirus" exact="infection" post="causes neuronal death in the absence of encephalitis in"/>
  <result pre="NetlandJ, MeyerholzDK, MooreSet al.Severe acute respiratory syndrome coronavirus infection causes" exact="neuronal" post="death in the absence of encephalitis in mice transgenic"/>
  <result pre="acute respiratory syndrome coronavirus infection causes neuronal death in the" exact="absence of" post="encephalitis in mice transgenic for human ACE2. J Virol."/>
  <result pre="syndrome coronavirus infection causes neuronal death in the absence of" exact="encephalitis" post="in mice transgenic for human ACE2. J Virol. 2008;82:7264â€&quot;75.18495771"/>
  <result pre="from fatal cases of SARS. PLoS Med. 2006;3:e27.16379499 PAGEFTreatment of" exact="lupus erythematosus" post="with mepacrine. Lancet. 1951;2:755â€&quot;8.14874500 PeeriNC, ShresthaN, RahmanMSet al.The SARS,"/>
  <result pre="Wuhan, China. Clin Infect Dis. 2020. Ramos-CasalsM, Brito-ZerÃ³nP, LÃ³pez-GuillermoAet al.Adult" exact="haemophagocytic syndrome." post="Lancet. 2014;383:1503â€&quot;16.24290661 RotzSJ, LeinoD, SzaboSet al.Severe cytokine release syndrome"/>
  <result pre="haemophagocytic syndrome. Lancet. 2014;383:1503â€&quot;16.24290661 RotzSJ, LeinoD, SzaboSet al.Severe cytokine release" exact="syndrome" post="in a patient receiving PD-1-directed therapy. Pediatr Blood Cancer."/>
  <result pre="cytokine release syndrome in a patient receiving PD-1-directed therapy. Pediatr" exact="Blood" post="Cancer. 2017;64. Ruiz-IrastorzaG, Ramos-CasalsM, Brito-ZeronPet al.Clinical efficacy and side"/>
  <result pre="Ramos-CasalsM, Brito-ZeronPet al.Clinical efficacy and side effects of antimalarials in" exact="systemic" post="lupus erythematosus: a systematic review. Ann Rheum Dis. 2010;69:20â€&quot;8.19103632"/>
  <result pre="Brito-ZeronPet al.Clinical efficacy and side effects of antimalarials in systemic" exact="lupus" post="erythematosus: a systematic review. Ann Rheum Dis. 2010;69:20â€&quot;8.19103632 RussellCD,"/>
  <result pre="al.Clinical aspects and outcomes of 70 patients with Middle East" exact="respiratory" post="syndrome coronavirus infection: a single-center experience in Saudi Arabia."/>
  <result pre="aspects and outcomes of 70 patients with Middle East respiratory" exact="syndrome" post="coronavirus infection: a single-center experience in Saudi Arabia. J"/>
  <result pre="2014;29:301â€&quot;6. SampathkumarP, TemesgenZ, SmithTFet al.SARS: epidemiology, clinical presentation, management, and" exact="infection" post="control measures. Mayo Clin Proc. 2003;78:882â€&quot;90.12839084 SaperVE, ChenG, DeutschGHet"/>
  <result pre="Mayo Clin Proc. 2003;78:882â€&quot;90.12839084 SaperVE, ChenG, DeutschGHet al.Emergent high fatality" exact="lung disease" post="in systemic juvenile arthritis. Ann Rheum Dis. 2019;78:1722â€&quot;31.31562126 SeguinA,"/>
  <result pre="Clin Proc. 2003;78:882â€&quot;90.12839084 SaperVE, ChenG, DeutschGHet al.Emergent high fatality lung" exact="disease" post="in systemic juvenile arthritis. Ann Rheum Dis. 2019;78:1722â€&quot;31.31562126 SeguinA,"/>
  <result pre="2003;78:882â€&quot;90.12839084 SaperVE, ChenG, DeutschGHet al.Emergent high fatality lung disease in" exact="systemic" post="juvenile arthritis. Ann Rheum Dis. 2019;78:1722â€&quot;31.31562126 SeguinA, GalicierL, BoutboulDet"/>
  <result pre="SaperVE, ChenG, DeutschGHet al.Emergent high fatality lung disease in systemic" exact="juvenile" post="arthritis. Ann Rheum Dis. 2019;78:1722â€&quot;31.31562126 SeguinA, GalicierL, BoutboulDet al.Pulmonary"/>
  <result pre="Dis. 2019;78:1722â€&quot;31.31562126 SeguinA, GalicierL, BoutboulDet al.Pulmonary involvement in patients with" exact="hemophagocytic lymphohistiocytosis." post="Chest. 2016;149:1294â€&quot;301.26836913 ShakooryB, CarcilloJA, ChathamWWet al.Interleukin-1 receptor blockade is"/>
  <result pre="CherryCet al.Tocilizumab for the management of immune mediated adverse events" exact="secondary" post="to PD-1 blockade. J Oncol Pharm Pract. 2019;25:551â€&quot;7.29207939 TanakaT,"/>
  <result pre="protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe" exact="acute" post="respiratory syndrome. Clin Chem. 2005;51:2333â€&quot;40.16195357 TseGM, ToKF, ChanPKet al.Pulmonary"/>
  <result pre="(CXCL-10) and other chemokines predicts adverse outcome in severe acute" exact="respiratory" post="syndrome. Clin Chem. 2005;51:2333â€&quot;40.16195357 TseGM, ToKF, ChanPKet al.Pulmonary pathological"/>
  <result pre="TseGM, ToKF, ChanPKet al.Pulmonary pathological features in coronavirus associated severe" exact="acute" post="respiratory syndrome (SARS). J Clin Pathol. 2004;57:260â€&quot;5.14990596 VargaZ, FlammerA,"/>
  <result pre="ToKF, ChanPKet al.Pulmonary pathological features in coronavirus associated severe acute" exact="respiratory" post="syndrome (SARS). J Clin Pathol. 2004;57:260â€&quot;5.14990596 VargaZ, FlammerA, SteigerPet"/>
  <result pre="ChanPKet al.Pulmonary pathological features in coronavirus associated severe acute respiratory" exact="syndrome" post="(SARS). J Clin Pathol. 2004;57:260â€&quot;5.14990596 VargaZ, FlammerA, SteigerPet al.Endothelial"/>
  <result pre="(SARS). J Clin Pathol. 2004;57:260â€&quot;5.14990596 VargaZ, FlammerA, SteigerPet al.Endothelial cell" exact="infection" post="and endotheliitis in COVID-19. Lancet. 2020;395:1417â€&quot;8.32325026 collab: Viruses ICoTo"/>
  <result pre="WanS, YiQ, FanSet al.Characteristics of lymphocyte subsets and cytokines in" exact="peripheral" post="blood of 123 hospitalized patients with 2019 novel coronavirus"/>
  <result pre="peripheral blood of 123 hospitalized patients with 2019 novel coronavirus" exact="pneumonia" post="(NCP). medRxiv. 2020, 10.1101/2020.02.10.20021832. collab: World Health OrganizationConsensus Document"/>
  <result pre="10.1101/2020.02.10.20021832. collab: World Health OrganizationConsensus Document on the Epidemiology of" exact="Severe" post="acute Respiratory Syndrome (SARS). 2003. collab: World Health OrganizationCoronavirus"/>
  <result pre="collab: World Health OrganizationConsensus Document on the Epidemiology of Severe" exact="acute" post="Respiratory Syndrome (SARS). 2003. collab: World Health OrganizationCoronavirus disease"/>
  <result pre="World Health OrganizationConsensus Document on the Epidemiology of Severe acute" exact="Respiratory" post="Syndrome (SARS). 2003. collab: World Health OrganizationCoronavirus disease (COVID-19)"/>
  <result pre="Health OrganizationConsensus Document on the Epidemiology of Severe acute Respiratory" exact="Syndrome" post="(SARS). 2003. collab: World Health OrganizationCoronavirus disease (COVID-19) Pandemic."/>
  <result pre="Severe acute Respiratory Syndrome (SARS). 2003. collab: World Health OrganizationCoronavirus" exact="disease" post="(COVID-19) Pandemic. 2020, April 22. collab: World Health OrganizationMiddle"/>
  <result pre="(COVID-19) Pandemic. 2020, April 22. collab: World Health OrganizationMiddle East" exact="Respiratory" post="Syndrome Coronavirus (MERS-CoV). 2019, March 11. collab: World Health"/>
  <result pre="Pandemic. 2020, April 22. collab: World Health OrganizationMiddle East Respiratory" exact="Syndrome" post="Coronavirus (MERS-CoV). 2019, March 11. collab: World Health OrganizationQ&amp;amp;A"/>
  <result pre="coronaviruses (COVID-19). 2020, April 17. collab: World Health OrganizationSARS (Severe" exact="Acute" post="Respiratory Syndrome). 2020. WuJ, LiuJ, ZhaoXet al.Clinical characteristics of"/>
  <result pre="(COVID-19). 2020, April 17. collab: World Health OrganizationSARS (Severe Acute" exact="Respiratory" post="Syndrome). 2020. WuJ, LiuJ, ZhaoXet al.Clinical characteristics of imported"/>
  <result pre="10.1093/cid/ciaa199. XuZ, ShiL, WangYet al.Pathological findings of COVID-19 associated with" exact="acute" post="respiratory distress syndrome. Lancet Respir Med. 2020;8:420â€&quot;2.32085846 ZengH, XuC,"/>
  <result pre="XuZ, ShiL, WangYet al.Pathological findings of COVID-19 associated with acute" exact="respiratory" post="distress syndrome. Lancet Respir Med. 2020;8:420â€&quot;2.32085846 ZengH, XuC, FanJet"/>
  <result pre="With COVID-19 Pneumonia. JAMA. 2020;323:1848â€&quot;9. ZhaoW, ZhongZ, XieXet al.Relation between" exact="chest" post="CT findings and clinical conditions of coronavirus disease (COVID-19)"/>
  <result pre="al.Relation between chest CT findings and clinical conditions of coronavirus" exact="disease" post="(COVID-19) pneumonia: a multicenter study. AJR Am J Roentgenol."/>
  <result pre="YuT, DuRet al.Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: a retrospective cohort"/>
 </snippets>
</snippetsTree>
